AI & Crypto in One $11 Investment
Right now, you can harness the power of two bull markets... Artificial intelligence and cryptos...In one simple $11 investment.
Shares Stats
| Shares Outstanding | 61,933,800 |
| Shares Float | 55,028,187 |
| Shares Short | 12,552,898 |
| Insider Holdings | 441% |
| Institution Holdings | 57.36% |
About Omeros Corporation
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system (CNS), and immune-related diseases. It provides OMIDRIA for use in cataract surgery or intraocular lens replacement in the United States. The company's clinical programs include Narsoplimab (OMS721/MASP-2) for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA); that is in Phase III clinical trial for immunoglobulin A nephropathy (IgAN), atypical hemolytic uremic syndrome (aHUS), and COVID-19; and Phase II clinical trial to treat lupus nephritis and other renal diseases. Its clinical programs also consist of PPAR? (OMS405) to treat opioid and nicotine addiction; PDE7 (OMS527) for treating addiction and compulsive disorders, and movement disorders; and MASP-3 (OMS906) for paroxysmal nocturnal hemoglobinuria (PNH) and other alternative pathway disorders. The company's preclinical programs comprise MASP-2-small-molecule inhibitors used for the treatment of aHUS, IgAN, HSCT-TMA, and age-related macular degeneration; longer-acting second generation antibody targeting MASP-2; and MASP-3-small-molecule inhibitors to treat PNH and other alternative pathway disorders. Its preclinical programs include G protein-coupled receptor (GPCR) platform, including GPR174, GPR151, GPR161, and other Class A orphan GPCRs for treating immunologic, immuno-oncologic, metabolic, CNS, cardiovascular, musculoskeletal, and other disorders. The company was incorporated in 1994 and is headquartered in Seattle, Washington.
General
| Name | Omeros Corporation |
| Ticker | OMER |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 277 |
Highlights
| Analyst Target | 27.33 |
| Market Cap | 1,231,863,296 |
| PE Ratio | -1.55 |
| PEG Ratio | -0.17 |
| EBITDA | -81,135,000 |
Financials
| Curr Year EPS Estimate | -1.77 |
| Next Quarter EPS Estimate | -0.54 |
| Profit Margin | -1.87 |
| Return on Assets | -0.43 |
| Revenue | 73,813,000 |
| Earnings Per Share | -2.42 |
| Revenue Per Share | 1.29 |
| Gross Profit | 6,169,000 |
| Quarterly Revenue Growth | -0.68 |
Valuation
| Price/Sales (Trailing 12 Mt.) | 15.40 |
Earnings
One Tech Tip: Protecting your car from the growing risk of keyless vehicle thefts
LONDON (AP) — They appear like ghosts in the night, standing outside your house, one holding up an antenna while the other crouches next to the car parked on the driveway. Within seconds, your car is gone, yet another victim amid enabled by the technology designed to make it easier to unlock and start vehicles.
Trump Vs. Biden: 2024 Election Poll Shows Tie Broken -- Which Candidate Gains Support From His Party, Independent Voters?
A new 2024 election poll shows a close race between Donald Trump and Joe Biden. One candidate gained ground with their party and Independent voters.
"America's No. 1 Retirement Stock" (Name Inside) - Ad
According to the former Goldman Sachs VP -- who wrote a best-selling book on retirement -- one single stock stands head-and-shoulders above all others. And it should be the cornerstone of your portfolio. Have you heard of it?
Mohamed El-Erian Says Bond And Equity Prices Getting A Boost After Softer-Than-Expected Headline CPI Numbers And Fueling 'Hopes For An Earlier Interest Rate Cut'
Mohamed El-Erian, the Chief Economic Advisor at Allianz, suggested that the latest inflation data could prompt the U.S. Federal Reserve to consider an earlier interest rate cut, potentially boosting bond and equity prices.
Floki Surpasses Heavyweights Shiba Inu And Solana In Popularity, Emerges As Market's Largest Gainer — Analyst Hopeful Of A 180-200% Bullish Rally
Floki (CRYPTO: FLOKI) extended its winning streak Wednesday, notching up impressive gains on the price charts and ranking high on social interactions.
Amazon's Betting Big on This Unknown AI Company - Ad
Amazon has just made a stunning $144 million investment in one small AI company. Why? Because this under-the-radar firm holds the key to unleashing the full potential of next-gen AI... Its technology is crucial for the most advanced AI chips, including Nvidia's latest breakthrough.
US prisoners are being assigned dangerous jobs. But what happens if they are hurt or killed?
PHOENIX (AP) — Blas Sanchez was nearing the end of a 20-year stretch in an Arizona prison when he was leased out to work at Hickman’s Family Farms, which sells eggs that end up in the supply chains of huge companies like McDonald’s, Target and Albertsons. While assigned to a machine that churns chicken droppings into compost, his right leg got pulled into a chute with a large spiraling augur.
Czech power company CEZ reports net profit of $592 million in Q1, up by a quarter year-on-year
PRAGUE (AP) — The Czech power company CEZ said Tuesday its net profit in the first quarter of the year reached 13.6 billion Czech crowns ($592 million), 2.7 billion up compared with the same period of the previous year.
Mystery of the Rich and Connected Revealed - Ad
Former Goldman VP reveals a mysterious "Gold Bank" with huge upside potential... Last time we shared this, some folks could have seen a 995% gain. Don't be surprised if you've never heard of this -- most haven't. But he's sharing all in this new video.
More trouble in Belgium for Miami-based 777 Partners after court authorizes seizure of assets
BRUSSELS (AP) — A Belgian court ruled Thursday that all assets in the country belonging to American investment group 777 Partners can be seized, in the latest legal setback for the embattled company that owns Standard de Liège and several other soccer clubs.
Amid Nvidia Craze, Jim Cramer Sees A Chip Stock 'Not On Anyone's Radar' About To Break Out: Here's What He Said
Despite it not being on anyone's radar, Jim Cramer believes that Broadcom is about to break out.
Nvidia's Secret Partner... This Is the New AI Chip Powerhouse - Ad
One unknown AI startup could match or even exceed AI's biggest runs in the coming years. Why? Because its technology solves the biggest problem holding back AI. It's a critical component that the industry can't advance without. This company just went public, so right now, it's under the radar.
Taiwan is selling more to the US than China in major shift away from Beijing
WASHINGTON (AP) — Whether it's tapioca balls or computer chips, Taiwan is stretching toward the United States and away from China — the world's No. 2 economy that threatens to by force if necessary.
New endangered listing for rare lizard could slow oil and gas drilling in New Mexico and West Texas
Federal wildlife officials declared a rare lizard in southeastern New Mexico and West Texas an endangered species Friday, citing future energy development, sand mining and climate change as the biggest threats to its survival in one of the world’s most lucrative oil and natural gas basins.
Must-See: Elon's New Invention is Absolutely Insane - Ad
When you click here and see what Elon Musk's new invention does... And how it works... You will NOT believe it. You'll tell yourself this is just science fiction. But Elon just tested this in a real human... And the result was mind-blowing.
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Microsoft's Satya Nadella To Employees: 'Prioritize Security Above New Features'
CEO Satya Nadella drives Microsoft's security overhaul in response to recent cyber threats, prioritizing protection post-breaches.
Earn Instant Cash Flow (using THIS tactic) - Ad
Can you imagine earning $1,118,721/hr? That's what greedy Wall Street elites have been pocketing for 22 straight years. And now it's available to you.
Palantir, Boeing, Lucid Group, Hims & Hers, Tesla: Why These 5 Stocks Are On Investors' Radars Today
On Monday, major U.S. stock indexes experienced gains, with the S&P500 closing nearly 1% higher at 5,180.74
Gov. Gavin Newsom: Authorities Seized $61M In Unlicensed Cannabis Products, Plants So Far This Year
California has reported stats on its crackdown on illegal cannabis operations, with state law enforcement seizing over $61 million worth...
Nvidia CEO Says It Will Spark "the Next Revolution" Beyond AI - Ad
Declares this radical biotechnology "is going to be flat out one of the biggest [tech revolutions] ever." And this $10 stock is at the center of all.
Federal Judge Indefinitely Postpones Donald Trump's Classified Documents Trial
The trial of ex-President Donald Trump for retaining classified documents has been postponed indefinitely by a federal judge.
Katy Perry and Rihanna didn't attend the Met Gala. But AI-generated images still fooled fans
NEW YORK (AP) — No, and didn't attend the this year. But that didn't stop AI-generated images from tricking some fans into thinking the stars made appearances on the steps of fashion's biggest night.
Forget AI, Imperium Is Expected to Grow 320,000% In 3 Years - Ad
Three of the world's biggest AI companies -- Google, Nvidia and Intel -- have even partnered with my No. 1 Imperium company to get on this massive mega trend. The average investor hasn't caught on yet, but you can still invest in my No. 1 Imperium company for just $10 a share.
Elon Musk Causes Stir With Response To Professor's Ominous Prediction Of Civil War 'Coming To The West'
Elon Musk raised eyebrows with his recent tweet affirming a prediction of a civil war in the West.
Psychedelics Surpass Cannabis With Unprecedented Bipartisan Support In Congress, Says Top VA Official
Speaking at a Horizons psychedelics conference, VA Under Secretary for Health Shereef Elnahal shared insights on psychedelic medicine
Central Banks Buying Gold in Record Numbers - Ad
Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can... Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars).
Elon Musk Issues Stark Warning Amid Rising National Debt: '...The Dollar Will Be Worth Nothing'
Elon Musk has voiced concerns about the future stability of the U.S. dollar, highlighting the escalating national debt as a potential catalyst for a looming economic crisis.
Bitcoin 'Could Still Have A Correction Down,' Cautions Lark Davis: 'Let's Not Get Ahead Of Ourselves'
In his latest podcast update, cryptocurrency trader Lark Davis previewed what could lay ahead for Bitcoin (CRYPTO: BTC) and different altcoins
5 Wall Street Legends Just Bought This One Stock - Ad
"If you're not at the table, you're on the menu," says former Goldman Sachs VP, Dr. David Eifrig.
Alibaba Shares Bounce Back Thursday: What's Going On?
Alibaba saw a rise in its shares Thursday afternoon after experiencing a decline on Tuesday following the release of its quarterly earnings report. Thursday's positive movement may be partly due to an X post from Citron Research.
Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects.
What's the Big Thing Musk, Bezos and Tim Cook All Have in Common? - Ad
One of America's most controversial CEOs says, "A new form of money in America is making some people (including Elon Musk, Jeff Bezos, and 17 of America's 25 wealthiest individuals), rich. It has nothing to do with gold, bitcoin, or anything like that, but it's 100% legal. The problem? Few Americans have a real understanding of how it works.
Nvidia Stock Faces Decline In Coming Years As AI Chip Demand Softens, Warns Analyst: 'We're Looking At The Horizon'
The future of Nvidia stock might not be as promising as its recent performance suggests, according to a prominent analyst.
Three groups are suing New Jersey to block an offshore wind farm
LONG BEACH TOWNSHIP, N.J. (AP) — Three anti-wind power groups are suing New Jersey to overturn a key environmental approval for a wind energy farm planned off the coast of Long Beach Island.
Could Elon's New Device be Bigger than the iPhone? - Ad
According to 30-year Silicon Valley and Wall Street veteran, Eric Fry... A man who picked 41 plays that jumped 1,000%+... This mind-blowing new technology could be bigger than the iPhone. And it could make a lot of people wealthy in the coming months and years.
Supreme Court rejects Musk appeal over tweets that must be approved by Tesla
WASHINGTON (AP) — The Supreme Court on Monday rejected an appeal from over a settlement with securities regulators that requires him to get approval in advance of some tweets that relate to Tesla, the electric vehicle company he leads.
Donald Trump Says He's Not Concerned About His Legal Challenges: 'In A Way, I Don't Care ... Life Is Life'
In a recent private donor event in Florida, former President Donald Trump appeared unfazed by his ongoing legal issues.
Billionaires Are Now FLOODING Into Gold - Ad
Ray Dalio, John Paulson, and many others all recommend you own gold right now. But did you know there's another huge investor (worth more than all the world's billionaires COMBINED) buying gold by the ton? That's why the best move to make right now could be this little-known gold investment (which you can get started with for just $5).
OpenAI Chief Scientist That Quit Months After Participating In Coup Against Sam Altman, Likely To Join Elon Musk's xAI, Says Gene Munster: 'There's A 60% Chance'
Ilya Sutskever, former chief scientist at OpenAI, is speculated to possibly join Elon Musk's xAI following his departure, amidst significant internal changes and controversies at OpenAI.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.